Skip to main content
Clinical Trials/NCT00002090
NCT00002090
Completed
Not Applicable

An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

Pfizer6 sites in 1 countryAugust 31, 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mycobacterium Avium-Intracellulare Infection
Sponsor
Pfizer
Locations
6
Status
Completed
Last Updated
20 years ago

Overview

Brief Summary

To evaluate the efficacy and safety of two doses of azithromycin given chronically for the treatment of Mycobacterium avium bacteremia in AIDS patients.

Registry
clinicaltrials.gov
Start Date
August 31, 2001
End Date
TBD
Last Updated
20 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Pfizer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (6)

Loading locations...

Similar Trials